Disclosure outlining the policy to reduce the investment unit. Will carefully consider overall factors such as future performance, stock price levels, shareholder composition, and liquidity. If unclear, it is noted as ‘Unknown’.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"3349","jir_company_name":"Cosmos Pharmaceutical Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-08-28","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/08\/3349-20260828-01.pdf","jir_short_summary":"Disclosure outlining the policy to reduce the investment unit. Will carefully consider overall factors such as future performance, stock price levels, shareholder composition, and liquidity. If unclear, it is noted as 'Unknown'.","jir_summary":"### Section Heading\nThis document is titled 'Regarding the Concept and Policy for Reducing the Investment Unit' and explains the significance of reducing the investment unit and the future examination policy. The reduction of the investment unit is understood as a measure to expand the investor base and improve stock liquidity, but specific implementation timing and figures are not provided. Going forward, the policy is to consider performance, stock price level, shareholder composition, and liquidity in a comprehensive and careful manner.\n\n### Section 2 Heading\nThe text only states the reasons\/background for disclosure and the examination policy; there are no concrete implementation plans, schedules, or numerical impacts (such as dilution). There is no clear information on the impact on shareholders or next steps, and further disclosure will be needed.","jir_financial_highlights":"Unknown: Unknown (Unknown)","jir_category":"","jir_hashtags":"#CosmosPharmaceuticals, #StockMarket, #DisclosureUpdate","jir_key_figures":"Reduction consideration status\/ timing: Unknown\nSpecific reduction level: Unknown\nShareholder composition\/liquidity impact indicators: Unknown","jir_meta_title":"Cosmos Pharmaceutical Co., Ltd. Disclosure of Investment Unit Reduction Policy | August 2026","jir_meta_description":"Cosmos Pharmaceutical Co., Ltd. discloses the concept and policy on reducing the investment unit. Future examination policy will be pursued cautiously by comprehensively considering performance, stock price level, shareholder composition, and liquidity. Specific figures are unknown.","jir_og_title":"Cosmos Pharmaceutical Co., Ltd. Publishes Policy on Investment Unit Reduction","jir_og_description":"Cosmos Pharmaceutical Co., Ltd. announces its approach and policy regarding the reduction of the investment unit. Further details will be disclosed later.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":7750,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"disclosure_update","footnotes":""},"sector":[],"importance":[],"class_list":["post-108117","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n